Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05383079 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer

Study acronym: AlphaBet
StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 7, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Jun 2026 to Aug 1, 2026
    • Site details revised
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2022 to Sep 13, 2022
    • Site details revised
    v4
  4. Primary completion date: Aug 2025 to Jun 2026
    • Start date: Aug 2022 to Sep 2022
    • Eligibility criteria expanded, about 6 words
    v3
  5. Study title shortened, about 3 wordsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial will evaluate the safety of Radium-223 in combination with 177Lu-PSMA-I\&T in metastatic castration-resistant prostate cancer: Phase I/II study
Trial Details
NCT Number NCT05383079
Lead Sponsor Peter MacCallum Cancer Centre, Australia
Conditions
(from sponsor)		 Metastatic Castration-resistant Prostate Cancer, MCRPC, Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov